Intravenous flunitrazepam (Rohypnol) in conservative and restorative dentistry.
The study was undertaken to assess the suitability of intravenous flunitrazepam (Rohypnol) in patients requiring sedative cover for prolonged dental surgery. Fifty patients received up to 2 mg flunitrazepam to induce a satisfactory level of sedation. Further maintenance doses and local anaesthesia were given if required. The results showed the level of sedation and working conditions, as assessed by anaesthetist and surgeon, to be satisfactory in all but one patient. The majority of patients remained slightly drowsy the following morning but all stated they would undergo a similar procedure again.
D000328:Adult; D000766:Anesthesia, Dental; D003814:Dentistry, Operative; D005260:Female; D005445:Flunitrazepam / Q000008:administration & dosage / Q000494:pharmacology*; D006801:Humans; D007263:Infusions, Parenteral; D008297:Male; D008875:Middle Aged
D005445:Flunitrazepam